{
  "id": 1306,
  "text": "A 5-year DFS rate for the NACT arm and radiotherapy arm, respectively, of $7 7 .1 \\%$ and $6 4 .3 \\%$ in stages IB-IIA $\\mathrm { ( p < 0 .0 5 ) }$ ), $5 6 .2 \\%$ and $5 7 .1 \\%$ in stage IIB $\\mathrm { ( p > 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A 5-year DFS rate for the NACT arm and radiotherapy arm, respectively, of $7 7 .1 \\%$ and $6 4 .3 \\%$ in stages IB-IIA $\\mathrm { ( p < 0 .0 5 ) }$ ), $5 6 .2 \\%$ and $5 7 .1 \\%$ in stage IIB $\\mathrm { ( p > 0 .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在宫颈癌治疗中，对于分期为IB-IIA的患者，新辅助化疗组的5年无疾病生存率为77.1%，而放射治疗组为64.3%。对于分期为IIB的患者，新辅助化疗组的5年无疾病生存率为56.2%，放射治疗组为57.1%。这些数据表明，在不同的宫颈癌分期中，新辅助化疗和放射治疗在5年无疾病生存率上的表现有所不同。",
  "query": "在宫颈癌治疗中，不同分期的患者在接受新辅助化疗和放射治疗后，其5年无疾病生存率分别是多少？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在宫颈癌治疗中，不同分期的患者在接受新辅助化疗和放射治疗后，其5年无疾病生存率分别是多少？\n\n<reference text>: A 5-year DFS rate for the NACT arm and radiotherapy arm, respectively, of $7 7 .1 \\%$ and $6 4 .3 \\%$ in stages IB-IIA $\\mathrm { ( p < 0 .0 5 ) }$ ), $5 6 .2 \\%$ and $5 7 .1 \\%$ in stage IIB $\\mathrm { ( p > 0 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在宫颈癌治疗中，对于分期为IB-IIA的患者，新辅助化疗组的5年无疾病生存率为77.1%，而放射治疗组为64.3%。对于分期为IIB的患者，新辅助化疗组的5年无疾病生存率为56.2%，放射治疗组为57.1%。这些数据表明，在不同的宫颈癌分期中，新辅助化疗和放射治疗在5年无疾病生存率上的表现有所不同。"
}